204 related articles for article (PubMed ID: 11319169)
1. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior.
Xu LL; Wain JC; Miller DP; Thurston SW; Su L; Lynch TJ; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):303-9. PubMed ID: 11319169
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
[TBL] [Abstract][Full Text] [Related]
3. An association between a NQO1 genetic polymorphism and risk of lung cancer.
Saldivar SJ; Wang Y; Zhao H; Shao L; Lin J; Spitz MR; Wu X
Mutat Res; 2005 Apr; 582(1-2):71-8. PubMed ID: 15781212
[TBL] [Abstract][Full Text] [Related]
4. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
5. [Quinone oxidoreductase gene polymorphism and genetic susceptibility to nasopharyngeal carcinoma].
Wu DH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1126-7. PubMed ID: 12480594
[TBL] [Abstract][Full Text] [Related]
6. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
[TBL] [Abstract][Full Text] [Related]
7. NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study.
Bock CH; Wenzlaff AS; Cote ML; Land SJ; Schwartz AG
Carcinogenesis; 2005 Feb; 26(2):381-6. PubMed ID: 15498787
[TBL] [Abstract][Full Text] [Related]
8. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women.
Yin J; Vogel U; Ma Y; Qi R; Wang H
Cancer Genet Cytogenet; 2009 Jan; 188(1):26-31. PubMed ID: 19061777
[TBL] [Abstract][Full Text] [Related]
9. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
[TBL] [Abstract][Full Text] [Related]
10. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.
Butkiewicz D; Popanda O; Risch A; Edler L; Dienemann H; Schulz V; Kayser K; Drings P; Bartsch H; Schmezer P
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2242-6. PubMed ID: 15598786
[TBL] [Abstract][Full Text] [Related]
11. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
[TBL] [Abstract][Full Text] [Related]
12. Individual differences in lung cancer susceptibility in relation to polymorphisms of P-450IA1 gene and cigarette dose.
Kawajiri K; Nakachi K; Imai K; Hayashi S; Watanabe J
Princess Takamatsu Symp; 1990; 21():55-61. PubMed ID: 2134690
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic polymorphisms.
Fowke JH; Shu XO; Dai Q; Jin F; Cai Q; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1308-15. PubMed ID: 15298951
[TBL] [Abstract][Full Text] [Related]
14. Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer.
Marín MS; López-Cima MF; García-Castro L; Pascual T; Marrón MG; Tardón A
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1788-93. PubMed ID: 15533908
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between polymorphisms of DNA repair gene XRCC3 and susceptibility to lung cancer].
Zhang ZL; Zhou CC; Zhang J; Tang L; Su B
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Dec; 30(12):936-40. PubMed ID: 18336773
[TBL] [Abstract][Full Text] [Related]
16. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas.
Lyn-Cook BD; Yan-Sanders Y; Moore S; Taylor S; Word B; Hammons GJ
Cell Biol Toxicol; 2006 Mar; 22(2):73-80. PubMed ID: 16532285
[TBL] [Abstract][Full Text] [Related]
18. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Classen V; Bernges U; Philipp M
Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population.
Qiuling S; Yuxin Z; Suhua Z; Cheng X; Shuguang L; Fengsheng H
Carcinogenesis; 2003 Sep; 24(9):1499-503. PubMed ID: 12807740
[TBL] [Abstract][Full Text] [Related]
20. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
